CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in BIOA — BioAge Labs, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,700,323
+$2,375,466 QoQ
Shares Held
273,371
+10.6% QoQ
Ownership
0.596%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 151 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. BIOA ranks #28 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,700,323 | 273,371 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,324,857 | 247,276 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,908,509 | 219,842 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,125,332 | 191,383 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $496,888 | 120,312 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $338,313 | 89,977 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $491,379 | 84,867 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||